tasosartan has been researched along with Blood Pressure, High in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (57.14) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Antane, M; Bagli, JF; Chen, J; Collini, MD; Ellingboe, JW; Hartupee, D; Park, CH; Quagliato, D; Schmid, J; Tanikella, T; White, V | 1 |
| Schieffer, B; Schmidt, B | 1 |
| de Champlain, J; Gradman, AH; Lacourcière, Y; Larochelle, P; Pool, JL; Smith, WB; Svetkey, L | 1 |
| Buckalew, V; Chrysant, SG; Mroczek, WJ; Neutel, JM; Ruff, DA; Weber, M | 1 |
| Cléroux, J; Lacourcière, Y; Rhéaume, C; Waib, PH | 1 |
| Abernethy, DR; Andrawis, NS; Battle, MM; Burghart, PH; Klamerus, KJ; Mayer, P; Neefe, L; Weinryb, I | 1 |
| Allikmets, K; Franken, A; Häss, G; Parik, T; Skards, J; Viigimaa, M | 1 |
1 review(s) available for tasosartan and Blood Pressure, High
| Article | Year |
|---|---|
Angiotensin II AT1 receptor antagonists. Clinical implications of active metabolites.
Topics: Acrylates; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Growth Hormone; Humans; Hypertension; Imidazoles; Irbesartan; Losartan; Models, Molecular; Receptor, Angiotensin, Type 1; Tetrazoles; Thiophenes; Thromboxane A2 | 2003 |
5 trial(s) available for tasosartan and Blood Pressure, High
| Article | Year |
|---|---|
A randomized, double-blind, placebo-controlled, parallel-group, multicenter trial of four doses of tasosartan in patients with essential hypertension. Tasosartan Investigator's Group.
Topics: Adult; Aged; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Circadian Rhythm; Dose-Response Relationship, Drug; Double-Blind Method; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Placebos; Pyrimidines; Tetrazoles | 1998 |
Efficacy and tolerability of tasosartan, a novel angiotensin II receptor blocker: results from a 10-week, double-blind, placebo-controlled, dose-titration study. Tasosartan Investigators Group.
Topics: Adult; Aged; Angiotensin Receptor Antagonists; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Double-Blind Method; Drug Administration Schedule; Female; Humans; Hypertension; Male; Middle Aged; Pyrimidines; Severity of Illness Index; Tetrazoles; Treatment Outcome; United States | 1999 |
Effects of angiotensin antagonism with tasosartan on regional and systemic haemodynamics in hypertensive patients.
Topics: Adult; Angiotensin Receptor Antagonists; Blood Pressure; Double-Blind Method; Exercise Test; Female; Hemodynamics; Humans; Hypertension; Male; Middle Aged; Oxygen Consumption; Pyrimidines; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Tetrazoles; Vascular Resistance | 1998 |
A pharmacokinetic and pharmacodynamic study of the potential drug interaction between tasosartan and atenolol in patients with stage 1 and 2 essential hypertension.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Angiotensin II; Angiotensin Receptor Antagonists; Atenolol; Drug Synergism; Humans; Hypertension; Middle Aged; Pyrimidines; Single-Blind Method; Tetrazoles | 2000 |
Tasosartan and hydroclorothiazide as combination therapy in the treatment of severe essential hypertension: comparison with enalapril. Tasosartan Study Group.
Topics: Analysis of Variance; Angiotensin II; Antihypertensive Agents; Blood Pressure; Double-Blind Method; Drug Combinations; Enalapril; Humans; Hydrochlorothiazide; Hypertension; Middle Aged; Pyrimidines; Tetrazoles | 2000 |
1 other study(ies) available for tasosartan and Blood Pressure, High
| Article | Year |
|---|---|
Metabolites of the angiotensin II antagonist tasosartan: the importance of a second acidic group.
Topics: Administration, Oral; Adrenal Glands; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin II Type 2 Receptor Blockers; Angiotensin Receptor Antagonists; Animals; Blood Pressure; Heart Rate; Hypertension; In Vitro Techniques; Injections, Intravenous; Liver; Models, Molecular; Molecular Conformation; Pyridones; Pyrimidines; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Structure-Activity Relationship; Tetrazoles | 1998 |